Coag-Sense PT/INR System Commercialization & Support
Anticoagulation therapy monitoring (e.g., for atrial fibrillation, VTE)
CommercialActive
Key Facts
Indication
Anticoagulation therapy monitoring (e.g., for atrial fibrillation, VTE)
Phase
Commercial
Status
Active
Company
About CoaguSense
CoaguSense, founded in 2008, commercializes a point-of-care and home-use PT/INR monitoring system based on direct mechanical clot detection, a methodology considered the clinical gold standard. The company's portable device offers connectivity to EHRs and data management systems, targeting the large market of patients requiring anticoagulation management, particularly for conditions like atrial fibrillation. As a private company, it operates in the competitive in-vitro diagnostics (IVD) sector with a focused product line and a clear value proposition of accuracy and portability.
View full company profile